Founded at the Abramson Cancer Center at the University of Pennsylvania

Innovation and Access at the Mercy of Payment Policy: The Future of Chimeric Antigen Receptor Therapies

By Christopher R. Manz; David L. Porter; Justin E. Bekelman

Projects

Approaches to Foster Economic Sustainability of Precision Cancer Medicine and Cell Therapies

Innovation and Access at the Mercy of Payment Policy: The Future of Chimeric Antigen Receptor Therapies

Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology │ 2019

Christopher R. Manz; David L. Porter; Justin E. Bekelman